Bazi Bushen ameliorates age-related energy metabolism dysregulation by targeting the IL-17/TNF inflammatory pathway associated with SASP
Tóm tắt
Chronic inflammation and metabolic dysfunction are key features of systemic aging, closely associated with the development and progression of age-related metabolic diseases. Bazi Bushen (BZBS), a traditional Chinese medicine used to alleviate frailty, delays biological aging by modulating DNA methylation levels. However, the precise mechanism of its anti-aging effect remains unclear. In this study, we developed the Energy Expenditure Aging Index (EEAI) to estimate biological age. By integrating the EEAI with transcriptome analysis, we aimed to explore the impact of BZBS on age-related metabolic dysregulation and inflammation in naturally aging mice.
We conducted indirect calorimetry analysis on five groups of mice with different ages and utilized the data to construct EEAI. 12 -month-old C57BL/6 J mice were treated with BZBS or β-Nicotinamide Mononucleotide (NMN) for 8 months. Micro-CT, Oil Red O staining, indirect calorimetry, RNA sequencing, bioinformatics analysis, and qRT-PCR were performed to investigate the regulatory effects of BZBS on energy metabolism, glycolipid metabolism, and inflammaging.
The results revealed that BZBS treatment effectively reversed the age-related decline in energy expenditure and enhanced overall metabolism, as indicated by the aging index of energy expenditure derived from energy metabolism parameters across various ages. Subsequent investigations showed that BZBS reduced age-induced visceral fat accumulation and hepatic lipid droplet aggregation. Transcriptomic analysis of perirenal fat and liver indicated that BZBS effectively enhanced lipid metabolism pathways, such as the PPAR signaling pathway, fatty acid oxidation, and cholesterol metabolism, and improved glycolysis and mitochondrial respiration. Additionally, there was a significant improvement in inhibiting the inflammation-related arachidonic acid-linoleic acid metabolism pathway and restraining the IL-17 and TNF inflammatory pathways activated via senescence associated secretory phenotype (SASP).
BZBS has the potential to alleviate inflammation in metabolic organs of naturally aged mice and maintain metabolic homeostasis. This study presents novel clinical therapeutic approaches for the prevention and treatment of age-related metabolic diseases.
Từ khóa
Tài liệu tham khảo
Pontzer H, Yamada Y, Sagayama H, Ainslie PN, Andersen LF, Anderson LJ, et al. Daily energy expenditure through the human life course. Science. 2021;373:808–12. https://doi.org/10.1126/science.abe5017.
Zoico E, Rubele S, De Caro A, Nori N, Mazzali G, Fantin F, et al. Brown and beige adipose tissue and aging. Front Endocrinol. 2019;10:368. https://doi.org/10.3389/fendo.2019.00368.
Mancuso P, Bouchard B. The impact of aging on adipose function and adipokine synthesis. Front Endocrinol. 2019;10:137. https://doi.org/10.3389/fendo.2019.00137.
Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020;7:22. https://doi.org/10.3389/fcvm.2020.00022.
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186:243–78. https://doi.org/10.1016/j.cell.2022.11.001.
Manini TM. Energy expenditure and aging. Ageing Res Rev. 2010;9:1–11. https://doi.org/10.1016/j.arr.2009.08.002.
Drożdż K, Nabrdalik K, Hajzler W, Kwiendacz H, Gumprecht J, Lip GYH. Metabolic-associated fatty liver disease (mafld), diabetes, and cardiovascular disease: associations with fructose metabolism and gut microbiota. Nutrients. 2021. https://doi.org/10.3390/nu14010103.
Deprince A, Haas JT, Staels B. Dysregulated lipid metabolism links nafld to cardiovascular disease. Mol Metab. 2020;42: 101092. https://doi.org/10.1016/j.molmet.2020.101092.
Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol. 2021;18:689–700. https://doi.org/10.1038/s41569-021-00541-4.
Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther. 2022;7:391. https://doi.org/10.1038/s41392-022-01251-0.
Li X, Li C, Zhang W, Wang Y, Qian P, Huang H. Inflammation and aging: signaling pathways and intervention therapies. Signal Transduct Target Ther. 2023;8:239. https://doi.org/10.1038/s41392-023-01502-8.
Zhu X, Chen Z, Shen W, Huang G, Sedivy JM, Wang H, et al. Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention. Signal Transduct Target Ther. 2021;6:245. https://doi.org/10.1038/s41392-021-00646-9.
Kumari R, Jat P. Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype. Front Cell Dev Biol. 2021;9: 645593. https://doi.org/10.3389/fcell.2021.645593.
Wiley CD, Campisi J. The metabolic roots of senescence: mechanisms and opportunities for intervention. Nat Metab. 2021;3:1290–301. https://doi.org/10.1038/s42255-021-00483-8.
Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev. 2017;35:200–21. https://doi.org/10.1016/j.arr.2016.09.008.
Stahl EC, Delgado ER, Alencastro F, Lopresti ST, Wilkinson PD, Roy N, et al. Inflammation and ectopic fat deposition in the aging murine liver is influenced by ccr2. Am J Pathol. 2020;190:372–87. https://doi.org/10.1016/j.ajpath.2019.10.016.
Ogrodnik M, Miwa S, Tchkonia T, Tiniakos D, Wilson CL, Lahat A, et al. Cellular senescence drives age-dependent hepatic steatosis. Nat Commun. 2017;8:15691. https://doi.org/10.1038/ncomms15691.
Chung KW. Advances in understanding of the role of lipid metabolism in aging. Cells. 2021. https://doi.org/10.3390/cells10040880.
Hildebrandt X, Ibrahim M, Peltzer N. Cell death and inflammation during obesity: “know my methods, wat(son).” Cell Death Differ. 2023;30:279–92. https://doi.org/10.1038/s41418-022-01062-4.
Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137:111315. https://doi.org/10.1016/j.biopha.2021.111315.
Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576–90. https://doi.org/10.1038/s41574-018-0059-4.
Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505–22. https://doi.org/10.1038/s41569-018-0064-2.
Chaib S, Tchkonia T, Kirkland JL. Cellular senescence and senolytics: the path to the clinic. Nat Med. 2022;28:1556–68. https://doi.org/10.1038/s41591-022-01923-y.
Palmer AK, Xu M, Zhu Y, Pirtskhalava T, Weivoda MM, Hachfeld CM, et al. Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging Cell. 2019;18: e12950. https://doi.org/10.1111/acel.12950.
Xu M, Pirtskhalava T, Farr JN, Weigand BM, Palmer AK, Weivoda MM, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018;24:1246–56. https://doi.org/10.1038/s41591-018-0092-9.
Mbara KC, Devnarain N, Owira PMO. Potential role of polyphenolic flavonoids as senotherapeutic agents in degenerative diseases and geroprotection. Pharmaceut Med. 2022;36:331–52. https://doi.org/10.1007/s40290-022-00444-w.
Bjørklund G, Shanaida M, Lysiuk R, Butnariu M, Peana M, Sarac I, et al. Natural compounds and products from an anti-aging perspective. Molecules. 2022. https://doi.org/10.3390/molecules27207084.
Mora I, Arola L, Caimari A, Escoté X, Puiggròs F. Structured long-chain omega-3 fatty acids for improvement of cognitive function during aging. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms23073472.
Lam YY, Peterson CM, Ravussin E. Resveratrol vs. Calorie restriction: data from rodents to humans. Exp Gerontol. 2013;48:1018–24. https://doi.org/10.1016/j.exger.2013.04.005.
Bereswill S, Muñoz M, Fischer A, Plickert R, Haag L, Otto B, et al. Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS ONE. 2010;5: e15099. https://doi.org/10.1371/journal.pone.0015099.
Bisht K, Wagner K, Bulmer AC. Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and dna-protective dietary compounds. Toxicology. 2010;278:88–100. https://doi.org/10.1016/j.tox.2009.11.008.
Huang D, Hu H, Chang L, Liu S, Liang J, Song Y, et al. Chinese medicine bazi bushen capsule improves lipid metabolism in ovariectomized female apoe-/- mice. Ann Palliat Med. 2020;9:1073–83. https://doi.org/10.21037/apm-20-906.
Yu M, Hung T, Wang C, Wu S, Yang T, Yang C, et al. Neochlorogenic acid attenuates hepatic lipid accumulation and inflammation via regulating mir-34a in vitro. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms222313163.
Yan Y, Li Q, Shen L, Guo K, Zhou X. Chlorogenic acid improves glucose tolerance, lipid metabolism, inflammation and microbiota composition in diabetic db/db mice. Front Endocrinol. 2022;13:1042044. https://doi.org/10.3389/fendo.2022.1042044.
Zhou Y. The protective effects of cryptochlorogenic acid on β-cells function in diabetes in vivo and vitro via inhibition of ferroptosis. Diabetes Metabol Synd Obes. 2020;13:1921–31. https://doi.org/10.2147/DMSO.S249382.
Sun B, Zhang R, Liang Z, Fan A, Kang D. Hyperoside attenuates non-alcoholic fatty liver disease through targeting nr4a1 in macrophages. Int Immunopharmacol. 2021;94: 107438. https://doi.org/10.1016/j.intimp.2021.107438.
Lei P, Lü J, Yao T, Zhang P, Chai X, Wang Y, et al. Verbascoside exerts an anti-atherosclerotic effect by regulating liver glycerophospholipid metabolism. Food Sci Human Wellness. 2023;12:2314–23. https://doi.org/10.1016/j.fshw.2023.03.035.
Huang D, Wang X, Zhu Y, Gong J, Liang J, Song Y, et al. Bazi bushen capsule alleviates post-menopausal atherosclerosis via gper1-dependent anti-inflammatory and anti-apoptotic effects. Front Pharmacol. 2021;12: 658998. https://doi.org/10.3389/fphar.2021.658998.
Mao X, Hou Y, Fang C, Ma K, Zhang S, Guo Z, et al. Bazi bushen mitigates epigenetic aging and extends healthspan in naturally aging mice. Biomed Pharmacother. 2023;160: 114384. https://doi.org/10.1016/j.biopha.2023.114384.
Yeh C, Shen Z, Wang T, Kao C, Teng Y, Yeh T, et al. Hesperetin promotes longevity and delays aging via activation of cisd2 in naturally aged mice. J Biomed Sci. 2022;29:53. https://doi.org/10.1186/s12929-022-00838-7.
Lv J, Hu Y, Li L, He Y, Wang J, Guo N, et al. Targeting fabp4 in elderly mice rejuvenates liver metabolism and ameliorates aging-associated metabolic disorders. Metabolism Clin Exp. 2023;142:155528. https://doi.org/10.1016/j.metabol.2023.155528.
Meng F, Zhu X, Zhao H, Lu F, Lu Y, Lu Z. Improve production of pullulanase of bacillus subtilis in batch and fed-batch cultures. Appl Biochem Biotechnol. 2021;193:296–306. https://doi.org/10.1007/s12010-020-03419-2.
Agrawal S, Wang M, Klarqvist MDR, Smith K, Shin J, Dashti H, et al. Inherited basis of visceral, abdominal subcutaneous and gluteofemoral fat depots. Nat Commun. 2022;13:3771. https://doi.org/10.1038/s41467-022-30931-2.
Ponti F, Santoro A, Mercatelli D, Gasperini C, Conte M, Martucci M, et al. Aging and imaging assessment of body composition: from fat to facts. Front Endocrinol. 2019;10:861. https://doi.org/10.3389/fendo.2019.00861.
Luan J, Zhang C, Xu B, Xue Y, Ren Y. The predictive performances of random forest models with limited sample size and different species traits. Fish Res. 2020;227: 105534. https://doi.org/10.1016/j.fishres.2020.105534.
Qi Y. Random forest for bioinformatics. New York: Springer; 2012. p. 307–23.
Alves-Bezerra M, Cohen DE. Triglyceride metabolism in the liver. Compr Physiol. 2017;8:1–8. https://doi.org/10.1002/cphy.c170012.
Wang C, Hu M, Yi Y, Wen X, Lv C, Shi M, et al. Multiomic analysis of dark tea extract on glycolipid metabolic disorders in db/db mice. Front Nutr. 2022;9:1006517. https://doi.org/10.3389/fnut.2022.1006517.
Marangoni F, Agostoni C, Borghi C, Catapano AL, Cena H, Ghiselli A, et al. Dietary linoleic acid and human health: focus on cardiovascular and cardiometabolic effects. Atherosclerosis. 2020;292:90–8. https://doi.org/10.1016/j.atherosclerosis.2019.11.018.
Mousavi SM, Jalilpiran Y, Karimi E, Aune D, Larijani B, Mozaffarian D, et al. Dietary intake of linoleic acid, its concentrations, and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of prospective cohort studies. Diabetes Care. 2021;44:2173–81. https://doi.org/10.2337/dc21-0438.
Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, et al. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther. 2021;6:94. https://doi.org/10.1038/s41392-020-00443-w.
Chawengsub Y, Gauthier KM, Campbell WB. Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone. American journal of physiology. Heart Circ Physiol. 2009;297:H495–507. https://doi.org/10.1152/ajpheart.00349.2009.
Imig JD. Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol Rev. 2012;92:101–30. https://doi.org/10.1152/physrev.00021.2011.
Deng Y, Theken KN, Lee CR. Cytochrome p450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J Mol Cell Cardiol. 2010;48:331–41. https://doi.org/10.1016/j.yjmcc.2009.10.022.
Zha W, Edin ML, Vendrov KC, Schuck RN, Lih FB, Jat JL, et al. Functional characterization of cytochrome p450-derived epoxyeicosatrienoic acids in adipogenesis and obesity. J Lipid Res. 2014;55:2124–36. https://doi.org/10.1194/jlr.M053199.
Luria A, Bettaieb A, Xi Y, Shieh G, Liu H, Inoue H, et al. Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance. Proc Natl Acad Sci USA. 2011;108:9038–43. https://doi.org/10.1073/pnas.1103482108.
Lettieri-Barbato D, Aquilano K. Aging and immunometabolic adaptations to thermogenesis. Ageing Res Rev. 2020;63: 101143. https://doi.org/10.1016/j.arr.2020.101143.
Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018;19(6):371–84. https://doi.org/10.1038/s41576-018-0004-3.
Sayed N, Huang Y, Nguyen K, et al. An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging. Nat Aging. 2021;1:598–615. https://doi.org/10.1038/s43587-021-00082-y.
Rhoads TW, Anderson RM. Taking the long view on metabolism. Science. 2021;373:738–9. https://doi.org/10.1126/science.abl4537.
Amorim JA, Coppotelli G, Rolo AP, Palmeira CM, Ross JM, Sinclair DA. Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nat Rev Endocrinol. 2022;18:243–58. https://doi.org/10.1038/s41574-021-00626-7.
Kolb H, Kempf K, Martin S. Insulin and aging—a disappointing relationship. Front Endocrinol. 2023;14:1261298. https://doi.org/10.3389/fendo.2023.1261298.
Sachiko Araki MOSG. Impaired lipid metabolism in aged mice as revealed by fasting-induced expression of apolipoprotein mrnas in the liver and changes in serum lipids. Gerontology. 2004;4:206–15.
Duan J, Liu J, Ruan B, Ding J, Fang Z, Xu H, et al. Age-related liver endothelial zonation triggers steatohepatitis by inactivating pericentral endothelium-derived c-kit. Nature aging. 2023;3:258–74. https://doi.org/10.1038/s43587-022-00348-z.
Bartelt A, Heeren J. Adipose tissue browning and metabolic health. Nat Rev Endocrinol. 2014;10(1):24–36. https://doi.org/10.1038/nrendo.2013.204.
Scheja L, Heeren J. Metabolic interplay between white, beige, brown adipocytes and the liver. J Hepatol. 2016;64(5):1176–86. https://doi.org/10.1016/j.jhep.2016.01.025.
Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359–404. https://doi.org/10.1152/physrev.00033.2011.
Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715–25. https://doi.org/10.1016/S2213-8587(19)30084-1.
Johnson AA, Stolzing A. The role of lipid metabolism in aging, lifespan regulation, and age-related disease. Aging Cell. 2019;18: e13048. https://doi.org/10.1111/acel.13048.
Song R, Hu M, Qin X, Qiu L, Wang P, Zhang X, et al. The roles of lipid metabolism in the pathogenesis of chronic diseases in the elderly. Nutrients. 2023. https://doi.org/10.3390/nu15153433.
Baker SA, Rutter J. Metabolites as signalling molecules. Nat Rev Mol Cell Biol. 2023;24:355–74. https://doi.org/10.1038/s41580-022-00572-w.
Burns JL, Nakamura MT, Ma D. Differentiating the biological effects of linoleic acid from arachidonic acid in health and disease. Prostaglandins Leukot Essent Fatty Acids. 2018;135:1–4. https://doi.org/10.1016/j.plefa.2018.05.004.
Mohallem R, Aryal UK. Regulators of tnfα mediated insulin resistance elucidated by quantitative proteomics. Sci Rep. 2020;10:20878. https://doi.org/10.1038/s41598-020-77914-1.
Huangfu L, Li R, Huang Y, Wang S. The il-17 family in diseases: from bench to bedside. Signal Transduct Target Ther. 2023;8:402. https://doi.org/10.1038/s41392-023-01620-3.
Girbl T, Lenn T, Perez L, Rolas L, Barkaway A, Thiriot A, et al. Distinct compartmentalization of the chemokines cxcl1 and cxcl2 and the atypical receptor ackr1 determine discrete stages of neutrophil diapedesis. Immunity. 2018;49:1062–76. https://doi.org/10.1016/j.immuni.2018.09.018.
De Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, Hartmann K, et al. Mast cell and macrophage chemokines cxcl1/cxcl2 control the early stage of neutrophil recruitment during tissue inflammation. Blood. 2013;121:4930–7. https://doi.org/10.1182/blood-2013-02-486217.
Sullivan DE, Ferris M, Nguyen H, Abboud E, Brody AR. Tnf-alpha induces tgf-beta1 expression in lung fibroblasts at the transcriptional level via ap-1 activation. J Cell Mol Med. 2009;13:1866–76. https://doi.org/10.1111/j.1582-4934.2009.00647.x.
Thiel G, Rössler OG. Resveratrol stimulates ap-1-regulated gene transcription. Mol Nutr Food Res. 2014;58:1402–13. https://doi.org/10.1002/mnfr.201300913.